Marinus Pharmaceuticals Inc (MRNS)
1.405
-0.02
(-1.06%)
USD |
NASDAQ |
Apr 26, 16:00
1.41
0.00 (0.00%)
Pre-Market: 20:00
Marinus Pharmaceuticals 1 Year Total Returns (Daily): -83.03% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -83.03% |
April 25, 2024 | -82.66% |
April 24, 2024 | -82.80% |
April 23, 2024 | -82.22% |
April 22, 2024 | -81.79% |
April 19, 2024 | -82.92% |
April 18, 2024 | -82.83% |
April 17, 2024 | -82.02% |
April 16, 2024 | -83.76% |
April 15, 2024 | -82.41% |
April 12, 2024 | 6.67% |
April 11, 2024 | 12.82% |
April 10, 2024 | 15.24% |
April 09, 2024 | 27.16% |
April 08, 2024 | 24.43% |
April 05, 2024 | 21.68% |
April 04, 2024 | 29.55% |
April 03, 2024 | 24.29% |
April 02, 2024 | 28.55% |
April 01, 2024 | 30.00% |
March 28, 2024 | 44.87% |
March 27, 2024 | 41.37% |
March 26, 2024 | 41.77% |
March 25, 2024 | 44.03% |
March 22, 2024 | 46.83% |
Date | Value |
---|---|
March 21, 2024 | 44.39% |
March 20, 2024 | 32.36% |
March 19, 2024 | 36.97% |
March 18, 2024 | 32.84% |
March 15, 2024 | 41.84% |
March 14, 2024 | 28.22% |
March 13, 2024 | 44.79% |
March 12, 2024 | 45.91% |
March 11, 2024 | 33.33% |
March 08, 2024 | 19.35% |
March 07, 2024 | 24.29% |
March 06, 2024 | 27.54% |
March 05, 2024 | 38.53% |
March 04, 2024 | 43.03% |
March 01, 2024 | 41.31% |
February 29, 2024 | 37.68% |
February 28, 2024 | 42.90% |
February 27, 2024 | 43.58% |
February 26, 2024 | 56.09% |
February 23, 2024 | 45.82% |
February 22, 2024 | 43.80% |
February 21, 2024 | 47.95% |
February 20, 2024 | 30.33% |
February 16, 2024 | 38.53% |
February 15, 2024 | 47.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.05%
Minimum
Jul 24 2019
269.5%
Maximum
Nov 20 2020
6.24%
Average
-17.10%
Median
1 Year Total Returns (Daily) Benchmarks
Ligand Pharmaceuticals Inc | -9.02% |
Soligenix Inc | -68.08% |
Actinium Pharmaceuticals Inc | -21.93% |
Macrogenics Inc | 113.5% |
ADMA Biologics Inc | 98.48% |